Report Detail

Request for Sample of this report

Other Global Lyme Disease Diagnostic Service Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4626407
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Lyme Disease Diagnostic Service market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Lyme Disease Diagnostic Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lyme Disease Diagnostic Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Lyme Disease Diagnostic Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Lyme Disease Diagnostic Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Lyme Disease Diagnostic Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lyme Disease Diagnostic Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lyme Disease Diagnostic Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quidel Corporation, Roche Holding AG, Fujirebio（H.U. Group Holdings）, ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), BioMerieux, Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Lyme Disease Diagnostic Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ELISA
Western Blotting
PCR
Others
Market segment by Application
Individual
Hospitals and Testing Institutions
Others
Market segment by players, this report covers
Quidel Corporation
Roche Holding AG
Fujirebio（H.U. Group Holdings）
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lyme Disease Diagnostic Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lyme Disease Diagnostic Service, with revenue, gross margin, and global market share of Lyme Disease Diagnostic Service from 2020 to 2025.
Chapter 3, the Lyme Disease Diagnostic Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Lyme Disease Diagnostic Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lyme Disease Diagnostic Service.
Chapter 13, to describe Lyme Disease Diagnostic Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Lyme Disease Diagnostic Service by Type
    • 1.3.1 Overview: Global Lyme Disease Diagnostic Service Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Lyme Disease Diagnostic Service Consumption Value Market Share by Type in 2024
    • 1.3.3 ELISA
    • 1.3.4 Western Blotting
    • 1.3.5 PCR
    • 1.3.6 Others
  • 1.4 Global Lyme Disease Diagnostic Service Market by Application
    • 1.4.1 Overview: Global Lyme Disease Diagnostic Service Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Individual
    • 1.4.3 Hospitals and Testing Institutions
    • 1.4.4 Others
  • 1.5 Global Lyme Disease Diagnostic Service Market Size & Forecast
  • 1.6 Global Lyme Disease Diagnostic Service Market Size and Forecast by Region
    • 1.6.1 Global Lyme Disease Diagnostic Service Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Lyme Disease Diagnostic Service Market Size by Region, (2020-2031)
    • 1.6.3 North America Lyme Disease Diagnostic Service Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Lyme Disease Diagnostic Service Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Lyme Disease Diagnostic Service Market Size and Prospect (2020-2031)
    • 1.6.6 South America Lyme Disease Diagnostic Service Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Lyme Disease Diagnostic Service Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Quidel Corporation
    • 2.1.1 Quidel Corporation Details
    • 2.1.2 Quidel Corporation Major Business
    • 2.1.3 Quidel Corporation Lyme Disease Diagnostic Service Product and Solutions
    • 2.1.4 Quidel Corporation Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Quidel Corporation Recent Developments and Future Plans
  • 2.2 Roche Holding AG
    • 2.2.1 Roche Holding AG Details
    • 2.2.2 Roche Holding AG Major Business
    • 2.2.3 Roche Holding AG Lyme Disease Diagnostic Service Product and Solutions
    • 2.2.4 Roche Holding AG Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Roche Holding AG Recent Developments and Future Plans
  • 2.3 Fujirebio（H.U. Group Holdings）
    • 2.3.1 Fujirebio（H.U. Group Holdings） Details
    • 2.3.2 Fujirebio（H.U. Group Holdings） Major Business
    • 2.3.3 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product and Solutions
    • 2.3.4 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Fujirebio（H.U. Group Holdings） Recent Developments and Future Plans
  • 2.4 ZEUS Scientific
    • 2.4.1 ZEUS Scientific Details
    • 2.4.2 ZEUS Scientific Major Business
    • 2.4.3 ZEUS Scientific Lyme Disease Diagnostic Service Product and Solutions
    • 2.4.4 ZEUS Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 ZEUS Scientific Recent Developments and Future Plans
  • 2.5 IGeneX
    • 2.5.1 IGeneX Details
    • 2.5.2 IGeneX Major Business
    • 2.5.3 IGeneX Lyme Disease Diagnostic Service Product and Solutions
    • 2.5.4 IGeneX Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 IGeneX Recent Developments and Future Plans
  • 2.6 Thermo Fisher Scientific
    • 2.6.1 Thermo Fisher Scientific Details
    • 2.6.2 Thermo Fisher Scientific Major Business
    • 2.6.3 Thermo Fisher Scientific Lyme Disease Diagnostic Service Product and Solutions
    • 2.6.4 Thermo Fisher Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.7 Everlywell
    • 2.7.1 Everlywell Details
    • 2.7.2 Everlywell Major Business
    • 2.7.3 Everlywell Lyme Disease Diagnostic Service Product and Solutions
    • 2.7.4 Everlywell Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Everlywell Recent Developments and Future Plans
  • 2.8 Oxford Immunotec Global PLC(PerkinElmer)
    • 2.8.1 Oxford Immunotec Global PLC(PerkinElmer) Details
    • 2.8.2 Oxford Immunotec Global PLC(PerkinElmer) Major Business
    • 2.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product and Solutions
    • 2.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
  • 2.9 BioMerieux
    • 2.9.1 BioMerieux Details
    • 2.9.2 BioMerieux Major Business
    • 2.9.3 BioMerieux Lyme Disease Diagnostic Service Product and Solutions
    • 2.9.4 BioMerieux Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 BioMerieux Recent Developments and Future Plans
  • 2.10 Bio-Rad Laboratories
    • 2.10.1 Bio-Rad Laboratories Details
    • 2.10.2 Bio-Rad Laboratories Major Business
    • 2.10.3 Bio-Rad Laboratories Lyme Disease Diagnostic Service Product and Solutions
    • 2.10.4 Bio-Rad Laboratories Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.11 T2 Biosystems
    • 2.11.1 T2 Biosystems Details
    • 2.11.2 T2 Biosystems Major Business
    • 2.11.3 T2 Biosystems Lyme Disease Diagnostic Service Product and Solutions
    • 2.11.4 T2 Biosystems Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 T2 Biosystems Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Lyme Disease Diagnostic Service Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Lyme Disease Diagnostic Service by Company Revenue
    • 3.2.2 Top 3 Lyme Disease Diagnostic Service Players Market Share in 2024
    • 3.2.3 Top 6 Lyme Disease Diagnostic Service Players Market Share in 2024
  • 3.3 Lyme Disease Diagnostic Service Market: Overall Company Footprint Analysis
    • 3.3.1 Lyme Disease Diagnostic Service Market: Region Footprint
    • 3.3.2 Lyme Disease Diagnostic Service Market: Company Product Type Footprint
    • 3.3.3 Lyme Disease Diagnostic Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Lyme Disease Diagnostic Service Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Lyme Disease Diagnostic Service Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Lyme Disease Diagnostic Service Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Lyme Disease Diagnostic Service Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Lyme Disease Diagnostic Service Consumption Value by Type (2020-2031)
  • 6.2 North America Lyme Disease Diagnostic Service Market Size by Application (2020-2031)
  • 6.3 North America Lyme Disease Diagnostic Service Market Size by Country
    • 6.3.1 North America Lyme Disease Diagnostic Service Consumption Value by Country (2020-2031)
    • 6.3.2 United States Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Lyme Disease Diagnostic Service Consumption Value by Type (2020-2031)
  • 7.2 Europe Lyme Disease Diagnostic Service Consumption Value by Application (2020-2031)
  • 7.3 Europe Lyme Disease Diagnostic Service Market Size by Country
    • 7.3.1 Europe Lyme Disease Diagnostic Service Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 7.3.3 France Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Lyme Disease Diagnostic Service Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Lyme Disease Diagnostic Service Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region
    • 8.3.1 Asia-Pacific Lyme Disease Diagnostic Service Consumption Value by Region (2020-2031)
    • 8.3.2 China Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 8.3.5 India Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Lyme Disease Diagnostic Service Consumption Value by Type (2020-2031)
  • 9.2 South America Lyme Disease Diagnostic Service Consumption Value by Application (2020-2031)
  • 9.3 South America Lyme Disease Diagnostic Service Market Size by Country
    • 9.3.1 South America Lyme Disease Diagnostic Service Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Lyme Disease Diagnostic Service Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Lyme Disease Diagnostic Service Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country
    • 10.3.1 Middle East & Africa Lyme Disease Diagnostic Service Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Lyme Disease Diagnostic Service Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Lyme Disease Diagnostic Service Market Drivers
  • 11.2 Lyme Disease Diagnostic Service Market Restraints
  • 11.3 Lyme Disease Diagnostic Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Lyme Disease Diagnostic Service Industry Chain
  • 12.2 Lyme Disease Diagnostic Service Upstream Analysis
  • 12.3 Lyme Disease Diagnostic Service Midstream Analysis
  • 12.4 Lyme Disease Diagnostic Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lyme Disease Diagnostic Service. Industry analysis & Market Report on Lyme Disease Diagnostic Service is a syndicated market report, published as Global Lyme Disease Diagnostic Service Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Lyme Disease Diagnostic Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo